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INTRODUCTION 
Atrial Fibrillation 
Atrial fibrillation (AF) is the commonest cardiac arrhythmia, and is 
increasing in frequency. Atrial fibrillation is an abnormal heart rhythm during 
which the upper  chambers of the heart beat irregularly. Normally the pacemaker 
of the heart generates an electrical impulse, which is conducted or carried to the 
lower or pumping chambers of the heart via the electrical conducting tissues of the 
heart. This allows a natural sequence of contraction where the upper chambers 
(atria) beat first, thus filling the lower chambers (ventricles). This sequence allows 
priming of the pumping chambers and contributes as much as 20% of the output of 
the heart. In atrial fibrillation, the heart’s natural pacemaker, the sinus node, no 
longer generates an electrical impulse. Instead electrical activity occurs irregularly 
throughout both left and right atria. This irregular electrical impulse is conducted 
erratically to the ventricles, resulting in an irregular heartbeat which may be 
excessively fast and vary in volume from beat to beat. The atrial electrical activity 
is very rapid (approximately 400 to 700 beats/min), but each electrical impulse 
results in the depolarization of only a small islet of atrial myocardium rather than 
the whole atrium. As a result, there is no contraction of the atria as a whole. Since 
there is no uniform atrial depolarization, there is no P wave. The chaotic electrical 
activity produces deflection on the ECG, referred to as fibrillatory wave. 
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Fibrillatory waves vary in size and shape and are irregular in rhythm. 
Transmission of these multiple atrial impulses into the AV node is thought to 
occur at random, resulting in an irregular ventricular rhythm. Some impulses are 
conducted into, but not through, the AV node; i.e., they are blocked within the AV 
node. This is a form of "concealed conduction" and is important since such non-
conducted impulses contribute to the overall refractoriness of the AV node. For 
this reason, the ventricular rate of atrial fibrillation is often slower (averaging 160 
to 180 beats/min) 
Today, more than 5% of those over 65 have AF. And most of these cases 
have underlying structural heart disease, which may be hypertensive, ischemic, or 
valvular in nature. The risk factors for AF include: male sex, hypertension, 
diabetes, thyrotoxicosis, heart failure, valvular disease, and excess alcohol intake. 
Rarely, AF occurs in a familial pattern; it's probable that more than one gene is 
involved. 
The chief consequence of AF is an increased likelihood of stroke; this 
occurs in 1.5% of persons with AF in their 50s, to a 23.5% risk for those in their 
80s. Mortality rates are doubled, in both sexes, due to stroke, heart failure, or 
myocardial infarction. 
When in atrial fibrillation the patient may feel his/her heart beating rapidly 
and irregularly (palpitation). Atrial fibrillation may cause chest pain, shortness of 
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breath, dizziness, weakness or fatigue. In some patients there are no accompanying 
symptoms. 
If atrial fibrillation causes chest pain, shortness of breath, dizziness or 
congestive heart failure, the arrhythmia may be dangerous and need to be 
corrected promptly. Usually however symptoms are not that severe and the 
arrhythmia may be dealt with less acutely. The major long-term danger of atrial 
fibrillation is an increased risk of congestive cardiac failure and stroke. The atria 
of the heart do not contract properly during atrial fibrillation. Blood flow is 
sluggish within the atria and this may lead to clot formation. If one of these clots 
breaks loose, it may travel to other parts of the body (embolism) resulting in stroke 
(cerebral embolism) or blockage of blood vessels throughout the body. Blockage 
of vessels to the limbs may cause inadequate blood supply (ischaemia) and 
endanger the limb. Similarly, blockage of a blood vessel in the abdomen may 
cause abdominal pain and bowel ischaemia, a condition that is life threatening. 
A typical ECG in atrial fibrillation shows a rapid irregular tachycardia in 
which recognizable P waves are absent. QRS complexes are generally normal, and 
the ventricular rate in patients with untreated atrial fibrillation generally ranges 
between 150 and 220 beats/min. However, in elderly patients, ventricular rates in 
untreated atrial fibrillation are typically slower. The ventricular rate may be 
accelerated in the presence of thyrotoxicosis, fever, catecholamines or 
catecholamine-like drugs, or conditions that enhance sympathetic tone. Although a 
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cardinal feature of atrial fibrillation is irregularity of the RR interval, at the most 
rapid ventricular rate, this irregularity may be somewhat difficult to discern. An 
increasing incidence and morbidity due to atrial fibrillation prompted to study the 
patients with atrial fibrillation in our institution. 
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AIM OF THE STUDY 
1. To Study age, sex distribution and etiologic analysis of atrial fibrillation  
2. To study the symptom profile of atrial fibrillation 
3. To assess left atrial size and relation of that to permanent atrial 
fibrillation 
4. To assess the incidence of Left atrial clot in cases of atrial fibrillation by 
Transesophageal Echo  
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REVIEW OF LITERATURE 
 
History : 
Evaluation of the peripheral pulse has fascinated physicians for centuries.  
Moses maimonides around 1187 described an irregular pulse.  Prior to the 
electrocardiographic confirmation of atrial fibrillation, many observant physicians 
commented on grossly irregular pulses that were likely to be atrial fibrillation. 
In 1904 Wenckebech published monograph on cardiac arrhythmias he 
described excessive irregularity or “delirium cordis”. 
Csuhny, Mackenzie, Rother Berger and Winter Beg especially Lawis made 
significant early observations concerning atrial fibrillation.  The pioneering work 
of Einthores enabled clinical investigators to record the electrographic 
representation of the clinical observation of atrial fibrillation. 
Pathology: 
The incidence of atrial fibrillation increase with age and it is especially 
prevalent in those aged 60 or greater.  Macroscopic and Microscopic alternations 
in the atrial tissue begin in the first year of life.  By fourth and fifth decades small 
fat spots appear in the right atrium in the region of AV node and septum.  These 
changes associated with ageing will result in loss of myocardial fibers and increase 
in fatty metamorphosis of connective tissue and focal hemorrhages in the sinus 
node, AV node and atrial structures.  One of the most important pathological 
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studies of atria in patients with atrial fibrillation was done by Davies and 
Pomerance.  In nearly 75 percentage of patients with chronic atrial fibrillation 
there was sinus node muscle loss, internodel tract muscle loss and atrial dilation. 
In case of rheumatic heart disease the left atrium is enlarged in almost all 
cases18,20.   In some cases of tight mitral stenosis  Aschoff bodies are found with  
in the atrial myocardium.  In other cases spindle shaped or triangular scar lying 
between the muscle bundles and surrounding blood vessels represent the healing 
of the Aschoff bodies 
MECHANISM OF ATRIAL FIBRILLATION 
The two chamber concept 
In an electrophysiological sense the heart consists of only two chambers 
one formed by the atria and the other formed by the ventricles. 
The two electrophysiological chambers are separated from each other by an 
electrical conduction barriers formed by the fibrous AV Ring.  Communication 
across these barriers under normal circumstances is only possible through the 
specialized conduction system formed by AV node, the bundle of His, the bundle 
branches and their ramifications. 
Each chambers is activated by single, coordinated, uniform and pro 
gressive excitation process which effects a total and almost simultaneous 
depolarization’s of the chamber.  All the fibers are rapidly brought to the same 
state of excitation.   
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Consequently  the fibers of the chambers will at any given moment be in 
the same or almost the same electrophysiological  state.  They will all be in a state 
of excitation or all in a state of potential responsiveness and when all the fibers of 
a chamber are uniformly in one state, they are said to be in phase with each other. 
In myocardial fibrillation the single uniform activation process is lost and the in 
phase state is transformed into a complex out of phase state.  A physiological 
fragmentation tissue is less in varying states of refractoriness, excitation and 
responsiveness occur. 
The pre disposition to any development of this state favored by the co 
incidence of two fundamental events: 
1. Uneven recovery of the chambers an out of phase state where one part of 
the chamber is responsive and another part of the chamber is refractory, 
a state of physiological asymmetry. 
2. Premature stimulation of chamber by an impulse that originates in or is 
introduced into the chamber before activation or recovery is complete. 
The Genesis of Physiological Asymmetry. 
The development of Physiological asymmetry with in the bi-atrial chamber 
is favored by: 
a. The mode of atrial activation longitudinal activation. 
b. Prolongation of conduction. 
c. Unequal conduction. 
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d. Increase in chamber size. 
e. The chamber asymmetry. 
f. Abbreviation in refractoriness 
g. Unequal refractoriness. 
 
A. The mode of Atrial activation: 
The most important factor predisposing to the development of atrial 
activation. 
Activation of the bi-atrial chamber occurs longitudinally and by contiguity 
spreading from its point of origin to engulf the whole chamber each fiber in turn 
activating the adjacent fibers.  The initial and terminal discrepancies resulting 
from longitudinal activation will in turn be affected by and depend upon factors 
such as the size and shape of the bi atrial chamber, the conduction time and the 
duration of the refractory period. 
B. Prolongation of Conduction: 
         A prolongation of conduction time will be associated with longitudinal 
activation, increasing the initial and terminal discrepancies. 
C. Unequal Conduction: 
Unequal conduction within the bi-atrial chamber will also potentiate simple 
out of phase state due to differences in intramural tension and disease process such 
as local ischemia. 
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D. Increase in chamber size: 
The larger the size of the chamber the greater the potential simple out of 
phase state and more readily will fibrillation be initiated and maintained.  Atrial 
fibrillation is especially common in cases of mitral  and tricuspid incompetence 
conditions which are usually associated with massive atrial enlargement.The 
AFFIRM3 study  noted that two thirds of patients with atrial fibrillation had 
siginificant left atrial dilatation. Adbou Elhendy et al20  in his study had repoted 
left atrial dilatation in 80% of AF of all causes.   
E. The chamber Asymmetry: 
The bi atrial chamber is asymmetrical and the pacemaker is eccentrically 
placed.  Consequently activation and recovery occurs sooner at a point close to the 
pace maker than at a point remote from the pacemaker.  The bizarre or 
asymmetrical shape of the bi atrial chamber will therefore, in the presence of 
longitudinal activation predispose towards the unequal recovery of the chamber. 
F. Abbreviation of refractoriness: 
A short refractory period when associated with a long or relatively long 
conduction times will also predispose to the maintenance of fibrillation. 
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G. Unequal refractoriness: 
Unequal refractoriness of the bi-atrial chamber will also aggregate the 
terminal out of phase discrepancy and predispose to atrial fibrillation. 
The maintenance of Atrial Fibrillation 
 The fibrillation will not be maintained unless there is a relatively short 
refractory period of parts of the myocardium and is associated with a long or 
relatively long conduction times. 
 Any condition which shortens the refractory period will facilitate the 
perpetuation of fibrillation. 
Following conditions shortens the refractory period: 
1. Acetycholine 
2. Vagal Stimulation 
3. Very low concentration of potassium 
4. High concentration of potassium 
5. Digitalis in toxic doses 
All these factors facilitate the precipitation and perpetuation of fibrillation.  
Atrial Fibrillation is mostly maintained in cases of tricuspid and mitral 
regurgitation that are associated with large atria. 
Causes of Premature atrial Stimulation: 
The development of an out of phase state with in the bi atrial chamber 
predisposes it to the precipitation of fibrillation by pre mature stimuli. 
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There are four Basic Sources of such premature stimuli: 
1. Atrial extra systoles. 
2. Atrial tachycardia. 
3. Reciprocal stimuli. 
4. A circus movement stimulus. 
1. Atrial extra systoles: 
Atrial extra systoles are pre mature impulses which arise from an ectopic 
atrial pace maker and these particularly will favor the initiation of fibrillation. 
2. Atrial Tachy Cardia: 
Tachycardia shortens the refractory periods but with very fast rates, the 
refractory periods is reduced to a critical level when it cannot shorten any further, 
it occupies virtually the complete diastolic interval.  When this occurs, successive 
impulse will tend to fall in the terminal out of phase period and may there by 
initiate fibrillation. 
3. Reciprocal Stimuli: 
Pre mature stimulation of atria is also facilitated by the presence of a by pass 
with in the AV conduction pathway.  The rapidly returning reciprocal impulse 
constitutes an early stimulus to the bi atrial chambers and may consequently 
initiate the fibrillation in the WPW syndrome and LGL syndromes. 
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4. A circus movement stimulus: 
A circus movement is a from of activation where in the excitation wave 
travels in a circular path around the bi atrial chamber.  The phenomenon occurs 
when the time taken for the excitation wave travel around the bi atrial chamber 
exceeds the refractory period.  . 
The mechanism is facilitated by the association of a long conduction time 
and a short refectory period.  A circus movement may be responsible mechanism 
in some cases of atrial flutter. 
Atrial flutter frequency precedes the atrial fibrillation.  The flutter 
constitutes a source of early stimulation by virtue of a circus movement of rapid 
repetitive stimulation and the flutter rate frequently increase just before the 
conversion to atrial fibrillation. 
A circus movement , reciprocal mechanism, atrial extra systoles, and 
atrialtachycardia are in the contest for basic mechanisms, but merely constitute 
sources of pre mature and or rapid stimulation. 
The aforementioned principles indicate that in the presence of longitudinal 
activation the initation of fibrillation is favored by enlargement of the bi atrial 
chamber, prolongation of conductions inequality of conduction, diminution of 
refractoriness and unequal refractoriness. 
 The mechanism of atrial fibrillation was the multiple hypothesis of Moe39.  
He noted, “The grossly irregular wave front becomes fractionated as it divides 
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about islets or strands of refractory tissue, and each daughter wavelets may now he 
considered as independent off spring such a wavelet may accelerate or decelerate 
as it encounters tissue in a more or less advanced state of new range” .  Thus more  
such wavelets present the more likely the arrhythmia will sustain.  The numbers of 
wavelets depends on the atrial mass, refractory period and conduction velocity of 
various areas of the atria.  In essence a large atrial mass with short refractory 
periods and conduction delay would yield increased wavelets and would be most 
favorable for sustaining atrial fibrillation. Recent observations on the initiation of 
AF from area of pulmonary veins40 & concept of fibrillatory conduit and rotors 
have rekindled the consideration of some older concepts. Atrial remodeling is 
considered to be an important determinant of the Pathophysiology40 where the 
modulating factors are endothelial dysfunction, hormonal, inflammatory mediators 
like Crp,IL-6. 
Electrocardiographic manifestations of Atrial Fibrillation. 
Atrial Fibrillation is characterized by the following electro cardiographic 
features. 
1. Irregular bizarre and chaotic atrial deflection – “F” waves which distort the 
base line. 
2. An irregular AV conduction sequences resulting in a completely irregular 
arrhythmia with variation in RR interval. 
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The atrial deflections. 
 Atrial activation is chaotic and virtually a self perpetuating process.  The 
atrial deflections are bizarre, irregular, chaotic and recorded contiguously and the 
atrial activation is instead reflected by variable, Irregularly corrugated, deflections 
which continuously deform the baseline.  These are inscribed at an irregular rate 
which raise from 400 to 600 waves / mt. 
 When “F” wave deflections are large in amplitude and low in frequency the 
condition is called; Atrial Fibrillation.  When these waves are rapid and are of 
small amplitude (< 1mm) the term “Fine” Atrial Fibrillation used.  In long 
standing atrial fibrillation. the fibrillatory waves may disappear leaving an almost 
smooth baseline is formed resembling atrial stand still. 
Some time regular flutter like large waves are seen for a few second 
followed by smaller irregular waves typical of Atrial Fibrillation. 
This condition is called impure flutter fibrillation. 
AV Conduction 
Conduction of impulses from the fibrillating atria may be complicated by 
a. Physiological second degree AV block 
b. High grade AV block 
c. Complete AV block 
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Atrial Fibrillation with physiological degree AV block. 
Here AV node offers block because of its inherent refractory period when 
AV node is bombard with a very large number of stimulus from the atria, which  
may fall on the refractory period of the AV node are blocked concealed 
conduction and conduction occurs only when the node recovers.   Because of the 
extreme irregularity of the atrial impulses the block also occurs irregularly and so 
the QRS complexes are placed at irregular intervals.  In this type of block the 
ventricular rate is usually between into beats / minute. 
At times the distributional pattern of the QRS complexes in atrial 
fibrillation suggests a Wenkeback form of AV conduction.  This is suggested by a 
progressive diminution in RR intervals followed by a long pause. 
ATRIAL FIBRILLATION WITH HIGH GRADE AV BLOCK 
This is characterized by idiondal or idiventricular escape beats that occurs 
regularly.  Here the longer intervals of QRS complexes the fibrillation remains 
constant. 
Atrial Fibrillation with Complete Heart Block 
This is characterized by slow and regular ventricular rate.  The beats are 
due to idionodal or idioventricular rhythm.  In the former rhythm the QRS 
complexes are narrow while in the later the complexes are wide and have bizarre 
shapes. 
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Intra Ventricular conditions: 
This may be normal or complicated by phasic aberrant conduction.  The 
phasic aberrations are temporary abnormalities in the ventricular conduction of 
supra ventricular impulses when impulses from above reach the ventricles at a 
rapid successions some times a QRS patterns is produced.  The successive 
impulses which reach the ventricles with sufficiently longs intervals produce 
normal QRS complexes.  These aberrant complexes are not attended by 
compensatory passes. 
Type of Atrial Fibrillation Based on: 
1. Ventricular Activity: 
Fast Atrial Fibrillation when the ventricular rate is more then 120 beats / mt. 
Slow atrial fibrillation: When the QRS complexes occur at a slow,  
rate 60-120 / min 
Both these terms are misnomers since the atrial rate is very high in both 
cases and the term fast and slow here applies to the ventricular rate. 
Atrial Fibrillation with regular ventricular rate: 
This occurs: 
a. In complete heart block with idionodal or idioventricular rhythm. 
b. After administration of drugs like verapamil. 
c. Junctional or ventricular tachycardia. 
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2. Duration: 
PAROXYSMAL ATRIAL FIBRILLATION :  A paroxysm of atrial 
fibrillation lasting less them 48 hrs.  This may be seen in normal subjects 
particularly during emotional stress on following surgery, exercise, acute alcoholic 
intoxication or a prominent surge of vagal tone.  It may also occur in patients with 
heart or lung disease who develop acute hypoxia, hyperpnea, metabolic or 
hemodynamic derangements45.  
Persistent Atrial Fibrillation: 
An episode of atrial fibrillation lasting greater than 48 hrs, which can still 
he converted to sinus rhythm.  Usually occurs in patients with cardio vascular 
disease, most commonly rheumatic heart disease, hypertensive cardio vascular 
disease, chronic lung disease, atrial septal defect any variety of miscellaneous 
cardiac abnormalities.    
Permanent Atrial Fibrillation:   
Inability of pharmacologic or non pharmacologic methods to restore sinus 
rhythm. 
So called lone Atrial Fibrillation which occurs in patients with out 
underlying heart disease often represents the tachy cardiac phase of the Tachy 
cardiac – Brady cardiac syndrome. 
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Etiology of Atrial Fibrillation: 
Essentially cardio vascular diseases: 
1. Rheumatic Heart Disease 
2. Coronary artery Heart Disease 
3. Hypertensive Heart Disease 
4. Cardiomyopathy 
- Dilated 
- Hypertrophic 
5. Congenital Heart Disease 
- ASD 
- Lutem Bacher’s syndrome 
- Tricuspid atresia 
- Ebstein anomaly 
- Corrected transport ion of great arteries 
6. Sick Sinus Syndrome 
7. Diffuse myocardial disease; myocarditis 
8. Pericardial Disease 
- Constrictive pericarditis 
- Pericardial effusion 
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9. Pre excitation syndromes 
- WPW syndrome 
- LGL syndrome 
10. Syphilitic Heart Disease 
11. Bacterial Endocarditis 
12. Atrial Mycenae 
13. Pulmonary heart disease 
14. Cardiac Surgery  
-Cardiac vascular surgery   
- Coronary artery surgery 
II Metabolic Diseases. 
1. Hyperthyroidism 
2. Hypothyroidism 
3. Hypokalemia 
4. Uremia 
III Intra Thoracic causes 
1. Pulmonary Embolism 
2. Labor Pneumonia 
3. After pneumonectomy 
4. Chronic lung disease 
5. Intra thoracic tumors infiltrating the heart. 
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IV Neurologic Disease 
1. Meningitis 
2. Meniere’s Syndrome 
3. Following Head Injury 
4. Emotional stress 
V Miscellaneous Causes 
1. During Anaesthesia 
2. Drugs and chemicals 
a. Alcohol 
b. Smoking 
c. Coffee 
d. Digitalis 
e. Adernaline 
3. Vomiting Spells 
4. Extreme exercise 
5. pregnancy 
VI Lone Atrial Fibrillation 
Idiopathic 
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RHEUMATIC VALVULAR HEART DISEASE: 
Cases of mitral and tricuspid valvular disease are frequently associated with 
atrial fibrillation because these conditions have the following pre disposing 
factors: 
a. Enlargement of the atria 
b. Prolongation of the Atrial conduction time 
c. Differential refractoriness of the atrial myocardium 
d. Atrial Extra systoles 
Rheumatic Valve disease especially is particularly important as it increases 
the thromboembolic risk of patients with chronic atrial fibrillation about 5 fold, up 
to a fifty% of patients with mitral valve stenosis and atrial fibrillation develop 
embolic events which in most cases affect the cerebral circulation. 
Echocardiography in such cases may show left atrial thrombus.  Trans esophageal 
echocardiography is more sensitive than transthoracic echocardiography21,42. 
Kaymaz et al21 had discerned the characteristics of left atrial thrombus 
predisposing to systemic embolism with transesophageal echocardiogram.  
Coronary Artery Disease: 
Ischemic heart disease is probably the most common underlying cause of 
atrial fibrillation in western countries.  In addition the fast ventricular rate due to 
atrial fibrillation may cause angina, leading to cardiac ischemia and heart failure 
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atrial fibrillation may complicate acute myocardial infarction in 10 to 15% of 
cases and is often a marker of extensive myocardial damage and poor prognosis 
with increased mortality.  It atrial fibrillation occurs with an acute myocardial 
infraction it tends to occur in the first 24 hrs and is usually self limiting. 
Atrial fibrillation is also a marker of underlying ventricular dysfunction and 
a compromised myocardium.  Many years after myocardial infarction, ventricular 
scarring and dilatation often predispose to atrial fibrillation and congestive cardiac 
failure. 
Hypertensive Heart Disease: 
Hypertension accounted for about half of the cases of atrial fibrillation in 
the Framingham study.  Hypertension contributes to the complication of stroke 
and thromboembolism in such patients, especially if left ventricular hypertrophy is 
present. 
Atrial fibrillation may be secondary to left atrial dilatation which occurs in 
hypertensive patients as a consequence of reduced left ventricular compliance.  In 
addition hypertension may be associated with underlying coronary artery disease, 
which itself is a risk for atrial fibrillation and thromboembolism. 
Congestive Cardiac Failure: 
Congestive cardiac failure from any cause may predispose to atrial 
fibrillation this is favored by associated enlarged atria and the consequent 
distension and stretch of the atrial walls. 
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Congenital Heart Disease: 
Atrial Fibrillation is common is two form of congenital heart diseases atrial 
septal defect and Ebstein anomaly.  In ASD the incidence of atrial fibrillation 
begin to increase starting from the fourth decade of life.  Epstein’s anomaly is 
commonly associated with atrial fibrillation often at an early age. 
Cardiac Surgery: 
Atrial Fibrillation is the most frequent arrhythmia noted after cardiac 
surgery patients undergoing coronary artery by pass graft surgery one of the 
largest group to have first episode of post operative Atrial Fibrillation. 
Post operative discontinuation of Beta Blocker’s taken regularly before 
surgery increases the risk of atrial fibrillation. 
Increased post operative sympathetic activity demonstrated by elevated 
norepinephrine levels is associated with increased risk of atrial fibrillation, 
minimally invasive cardiac surgery may not reduce the incidence of post operative 
atrial fibrillation. 
WPW – Syndrome: 
In WPW syndrome patients, an atrial dysarrythmia associated with an ante 
grade conducting accessory pathway can be life threatening.  Aberrant conduction 
usually occurs when a short RR interval follows a long RR interval (Ashman’s 
Phenomenon).  In those patients AV node blocking agents such a digitalis beta 
blockers or calcium channel blockers are contra indicated because they cause 
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ventricular fibrillation. Intravenous procainamide or lidocaine can be given. 
Radiofrequency ablation is the treatment of choice. 
Hypertrophic Cardiomyopathy: 
Approximately 15% of patients with hypertrophic cardiomyopathy develop 
atrial fibrillation.  In these individuals atrial fibrillation results in profound 
hemodynamic disturbance resulting in chest pain,  presyncope, syncope, and even 
sudden cardiac death. 
Tachy Cardia Induced Tachycardia: 
Tachycardia induced tachycardia is a phenomenon in which one tachy 
cardiac degenerates in to another tachycardia.  A relative common example is 
rapid ventricular tachy cardiac that degenerates in to ventricular fibrillation.  Atrial 
tachycardia and atrial flutter are likely to be the most common cause of 
tachycardia induced tachycardia resulting in atrial fibrillation.  
Hyperthyroidism 
Atrial Fibrillation is not uncommon in thyrotoxicosis.  Thyrotoxicosis is an 
important curable cause of atrial fibrillation .About 10 to 15 percent of patients 
with untreated thyrotoxicosis develop atrial fibrillation, it is more frequent in men  
and increase with age. 
Thyroid hormone affects the circulatory system and myocardium.  There is 
decrease in total systemic vascular resistance, an increase in total blood volume 
and decreased circulation time this leads to an increase in preloads and reduction 
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in after load.  There is also reduction in electrical threshold for excitation of atrium 
and increase in sinus rate. 
There appears to be an interaction between excess thyroid hormone and 
catecholamine action, including potentiation of catecholamine effects and 
increased number of cardiac beta adrenergic receptors. 
Thyrotoxicosis may be under diagnosed particularly in elderly people in 
whom classic signs of thyrotoxicosis may not be obvious.  One clinical clue may 
be the failure of digoxin to control the ventricular rate without the addition of 
betablockers.  Hyperthyroidism may coexist with both ischemic and rheumatic 
heart disease. 
Neurogenic Cause of Atrial Fibrillation: 
The sustained Atrial Fibrillation is facilitated by increased para 
symphathetic tone.  Atrial refractory period is decreased by acetylcholine which 
shortens the wave length making it easier for Atrial Fibrillation to sustain.  Atrial 
Fibrillation occurs during enhanced vagal tone for example onset of atrial 
fibrillation during swallowing cold substance, ice cream. 
Adrenergic form of Atrial Fibrillation has also been described.  The 
characteristics include 
a. On set during day time 
b. Preceded by emotional stimulus of exercise 
c. Polyuria common 
d. Atrial Fibrillation 
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With specific sinus rate.  Beta-blockers are the treatment or choice. 
Excess alcohol intake: 
Atrial Fibrillation due to an excess in take of alcohol often occurs after 
holidays or at week ends giving rise to the term “ Holiday Heart syndrome”.  
Alcohol can be associated with a dilated heart (alcoholic heart muscle disease) and 
atrial fibrillation. 
Pneumonia: 
Pneumonia is commonly associated with atrial fibrillation.  In about seven 
percent of cases, pneumonia as a precipitant of atrial fibrillation occurs pre 
dominantly in elderly patients. 
Idiopathic or Lone Atrial Fibrillation: 
Some patients with atrial fibrillation have no predisposing factor or cardiac 
lesion.  The condition in these patients is classified as “lone or idiopatic” Atrial 
Fibrillation. 
Familial Atrial Fibrillation: 
Familial atrial fibrillation is extremely uncommon seen relatively in young 
age less than 20years old.  The gene responsible for atrial fibrillation was located 
on chromosome 10g in the region of 10g22 to 10g24. 
Clinical Features of Atrial Fibrillation 
Symptoms: 
Palpitation 
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Dyspnoea 
Fatigue 
Angina 
Presyncope 
Syncope 
Atrial Fibrillation is associated with discrete group of symptoms.   
Palpitation being the most common.  Other frequent symptoms are dyspnea, 
fatigue and pre syncope and less common symptoms were chest pain and syncope.  
In a small group of patients atrial fibrillation as no symptoms.According to the 
Canadian Registry of Atrial fibrillation(CARAF) one fifth of patients were 
asymptomatic & palpitation was the leading symptom. 
Physical findings: 
Pulse is irregularly irregular.  Absence of “a” waves in the jugular venous 
pulse, results in a single positive wave form . 
With fast ventricular rates an apex-radial pulse deficit appears as each 
contraction may not be sufficiently strong to transmit an atrial pulse wave through 
the peripheral artery. 
The blood pressure reading depends upon the cause of atrial fibrillation and 
the cardiac status although the pulse pressure is generally variable. 
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Cardiac auscultation will reveal the variable intensity of the first heart 
sound because of the fluctuation in ventricular filling periods and the signs of 
underlying heart disease like mitral stenosis. 
COMPLICATIONS: 
Heart Failure: 
The sudden onset of fast atrial fibrillation may often precipitates overt heart 
failure particularly if left ventricular function is already compromised by 
coexisting heart disease for example valvular or ischemic heart disease. 
Heart disease is associated with atrial fibrillation in about 35 percent of 
cases.  In these patients atrial fibrillations may be a marker of increased mortality 
and may also enhance the substantial risk of thromboembolism. 
Thromboembolism: 
Atrial Fibrillation predisposes to the formation of intracardiac thrombus, 
which may result in stroke and thromboembolism.  The commonest site of 
thrombus is the left atrial appendage.  Right atrial thrombus with subsequent 
pulmonary thromboembolism is a rare complication. The Framingham heart study4 
correlated increased risk of stroke and death with increase in left atrial size. 
Goswami K.C et al41 reported 25% incidence of LA appendage clot and 50% 
incidence of spontaneous echo contrast with transesophageal echo study on 200 
patients with rheumatic mitral stenosis and af. Srimannarayanan44 J reported LA 
clots in one third of patients with severe MS and AF in their study on 490patients 
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and that LA appendage clots disappear with anticoagulants where as those 
extending to left atrial body may persist despite optimal anticoagulation.     
Stroke: 
The risk of stroke in some one with atrial fibrillation is about five percent a 
year, and epidemiological evidence suggest that the risk increase with age, raised 
blood pressure and other evidence of heart disease. Non rheumatic atrial 
fibrillation increased five fold the risk of stroke46.  Patients with atrial fibrillation 
may also have an increased risk of recurrent stroke and silent cerebral infarcts 
(often multiple) on computed tomography.  Patients with acute stroke and atrial 
fibrillation have a significant higher mortality than patients in sinus rhythm (23% 
vs 18% in the oxford community stroke project).  The higher mortality is 
explained partly by the association of atrial fibrillation with large, total anterior 
cerebral infarcts, probably due to occlusion of the middle cerebral artery. 
DIFFERENTIAL DIAGNOSIS: 
Atrial extrasystoles: 
Atrial extrasystoles occur commonly and may account for an irregular pulse 
leading to atrial fibrillation being wrongly diagnosed, long pauses may follow as 
sinus node automaticity is depressed by the extra systole.  Multifocal extrasystoles 
are particularly common in pulmonary disease. 
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Atrial Tachycardia: 
Atrial Tachycardia may simulate atrial fibrillation with rapid ventricular 
rate, “P” wave precede each QRS complex in atrial tachycardia, RR interval is 
perfect.  Carotid sinus massage may terminate a tachycardia and produce a regular 
and normal rate. 
Atrial Flutter: 
At times the rhytm may alternate between flutter and fibrillation in a single 
tracing.  There are border line cases where precise differentiation cannot be made 
(Flutter Fibrillation).  Atrial flutter and fibrillation form the extreme of the same 
spectrum of arrhythmias. 
Flutter waves are seen as regular saw tooth like atrial activity most 
prominent in the inferior leads. 
Atrial flutter is characterized by atrial rate between 250 and 350 beats / 
miutes typically, the ventricular rate is half.  The ventricular rate in 2:1 AV block 
is approximately 150 bpm.  If the atrial rate slowed to less than 220 beats per 
minute the ventricular rate may rise suddenly because of the development of 1:1 
AV conduction. 
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INVESTIGATIONS: 
Electrocardiography: 
The arrhythmias should be documented firstly with a  conventional 12 lead 
ECG.  This may provide a clue to the etiology or electrophysiological features that 
may cause arrhythmia for example ischemic heart disease, left ventricular 
hypertrophy or a preexitation syndrome. 
It was thought that coarse fibrillatory waves favour the etiology of 
rheumatic mitral valve disease or hyperthyroidism while five fibrillatory waves are 
associated with atherosclerotic or hypertensive cardio – vascular disease (Goldman 
1979).  This view is contradicted in recent studies. 
A 24 hour hotter monitor may be needed to document paroxysmal atrial 
fibrillation or sick sinus syndrome. 
Chest Radiography: 
A  chest radiography is useful in most cases of atrial fibrillation.  In a 
young patient it may provide a clue to congenital heart disease.  Such as ASD.     
X-Ray film can give information regarding the size of the heart and whether the 
patient has heart failure.  Barium swallows in appropriate cases show displacement 
of the esophagus. 
Blood Tests: 
Full blood counts – especially when anti coagulants are being considered. 
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Urea and electrolytes  - To establish baseline and if considering drug 
treatment. 
Thyroid function tests in suspected cases of hyperthyroidism. 
Rheumatic heart disease – ESR, ASO titres. 
Myocardial infarction – enzymes studies CPK – MB, Troponin ‘T’. 
Echocardiography: 
An echo cardiogram is an important test to obtain in patients with atrial 
fibrillation.  It allows the evaluation of atrial size, right and left ventricular 
function, presence of congenital and valvular lesions. 
Transesophageal echocardiography is valuable to investigate atrial function 
in patients with atrial fibrillation.  It provides information of the presence of 
thrombi prior to cardioversion, if such a procedure in contemplated. 
 
Exercise Testing: 
Exercise testing in necessary in some patients with IHD’s and atrial 
fibrillation to clarify the severity of underlying cardiac ischemia.  Exercise 
electrocardiography must be interpreted cautiously, how ever if treatment with 
digoxin is given such testing may also have a role in assessing the adequacy of 
drug treatment in controlling the ventricular response in atrial fibrillation. 
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Electrophysiology Studies: 
In patients with atrial fibrillation due to pre-excitation syndromes, 
electrophysiology studies may be needed to document the characteristics of 
conduction from the atria to the ventricles and the presence of accessory pathways.  
This may lead to a “Cure” of the condition by transcatheter ablation of the 
accessory pathway. 
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MATERIAL AND METHODS: 
This study was conducted at Govt. Stanley Medical College & Hospital, 
Chennai.  This study was conducted during the period of one year Jan 2004- 
December 2004, fifty cases of atrial fibrillation were included in this study.    No 
patient had been counted twice if he or she got admitted again after discharge 
during the period.   
The Diagnosis of Atrial Fibrillation: 
This is made on clinical grounds and then confirmed by electro 
cardiographic methods. 
Clinical Grounds: 
1. Irregularly irregular pulse : If the patient was not in failure he or she was 
exercised and the persistence of the irregularity is noted. 
2. Pulse deficit simultaneous counting of the pulse rates by on observer and 
the heart rate by another of one full minute. 
3. Absence of ‘a’ wave in the jugular venous pulsation, in areas where jugular 
venous pulsation is seen. 
4. On auscultation varying intensity of the first heart sound. 
5. Carotid sinus massage once again the irregularity persists though the heart 
rate is slowed 
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E.C.G Recording 
A 12 lead electrocardiograph was taken for all the cases.  It was 
standardized to produce a deflection of 10mm per 1mv input and the paper speed 
was set at 25mm per sound.  The ECG features of atrial fibrillation are 
1. Absence of regular rhythmic ‘P’ were 
2. Atrial activity is reflected by a variable irregularly corrugated deflection 
deforming the base line ‘F’ wave. 
3. Marked variation in RR Interval 
4. Variation in QRS complex configuration in ECG 
Other findings like left ventricular enlargement right ventricular 
enlargement, right bundle branch block, evidence of ischemia and infarction were 
also looked. 
In all cases, complete history was taken and general examination was done.  
Further points were noted according to the suspected etiology. 
Rheumatic Heart Disease: 
1. Features of Rheumatic fever (as per the updated Jones criteria published in 
1992, by the American Heart Association) 
2. Features of congestive cardiac failure (as per the Framingham criteria, 
circulation 88:107, 1993). 
3. The presence of valvular heart disease 
4. Features of infective endocarditis 
 37
5. E.C.G for ventricular hypertrophy patterns apart from Atrial Fibrillation. 
6. Plain X-Ray of PA view. 
Coronary Heart Disease: 
1. History 
2. Peripheral Arterial Thickening 
3. Auscultation for S3 and S4 (which may denote reduce compliance of the 
ventricles) 
4. Study of ocular funds. 
5. X-Ray for cardiomegaly, pulmonary congestion 
6. Serum enzymes and cholesterol. 
Hypertensive Heart Disease: 
Blood pressure, fundus examinations, E.C.G for left ventricular 
hypertrophy, X-Ray chest for cardiomegaly, Urine analysis, Blood urea level, if 
necessary other investigation to find out whether the hypertension is primary or 
secondary. 
Hyperthyroidism: 
Eye Signs 
Tremors 
Thyromegaly 
Sleeping pulse rate 
E.C.G 
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T3, T4, TSH with the help of private laboratories. 
Chest Radiography : 
A Posteroanterior view of the chest radiography was taken and evaluated 
for evidences of valvular heart disease, congenital heart disease, pericardial 
effusion chronic obstructive pulmonary disease, pneumonia etc., 
Echocardiography : 
M – Mode, 2-D, Echocardiography was done for all the patients.  The 
rhythm of the heart was  looked in to. The presence of thickening of valves, 
calcification and valve closure was noted, the size of the valve rings and chambers 
of the heart was assessed.  The appendages were specially looked and vegetations 
also noted.   Atrial enlargement , ventricular function also noted. They were also 
subjected to transesophageal echo for better characterization of LA clot42 as TEE 
is superior to TTE for the same. Under local anaesthetic spray, gastroscope like 
instrument with ultrasound probe was introduced and views taken45.  
Diagnosis of complications 
Atrial Fibrillation complicating cardiac failure patients, complete history 
and examination were done.  Electrocardiographic features, chest radiography for 
cardiomegaly and radiography for cardiomegaly and pulmonary congestion, 
echocardiographic evaluation of ventricular function were noted. 
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Atrial fibrillation complicating stroke, patients neurological examination 
done.  CT scan brain taken and the features were noted.  Stroke patients associated 
with atrial fibrillation the presence of thrombus in transesophageal 
echocardiogram also noted. 
 In atrial fibrillation patients features of infective endocarditis clinically 
evaluated.  In suspected patients three samples of blood culture taken one hour 
interval, and result noted.  Presence of vegetations in the echo cardiography also 
noted. 
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RESULTS 
 
TABLE 1 
AGE DISTRIBUTION 
Age in Years No. of Patients Percentage 
11-20 8 16% 
21-30 7 14% 
31-40 8 16% 
41-50 15 30% 
51-60 8 16% 
61-70 4 8% 
Total 50 100% 
         
The mean age was found to be 43 years.  Most of the patients belong to age 
group of 31-50 years. 
TABLE 2 
SEX DISTRIBUTION 
Sex No. of Patients Percentage 
Male 27 56% 
Female 23 44% 
 
Males were slightly more predominantly affected than females. 
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TABLE 3 
SYMPTOM ANALYSIS 
Leading Symptoms 
Breathlessness 35 (70%) 
Palpitation 30(60%) 
Weakness of limbs 7(14%) 
Chest Pain 3(6%) 
Syncope 1(2%) 
 
Leading Symptom was breathlessness found in 70% of patients and 5% of 
patients were asymptomatic.  No cases of Ortner’s syndrome or Bronchiectasis 
were found among the patients with mitral stenosis. 
TABLE 4 
ETIOLOGICAL ANALYSIS 
Etiology No: (%)  
RHD 35 (70) 
CongenitalHD 2 (4) 
Thyrotoxicosis 2 (4) 
IHD 6 (12) 
HTN 4 (8) 
Cardiomyopathy 1 (2) 
 
Rheumatic heart disease was the leading cause found in 70% of patients.  
The second commonest being ischemic heart disease was found in 12%. 
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TABLE 5 
TYPE OF VALVULAR LESION 
Total Number- 35 cases of  RHD 
Type of Valve Disease No. of Patients 
MS 18 (50%) 
MR 5 (16%) 
MS + MR 10 (28%) 
MS+AR+AS 2 (6%) 
 
Isolated Mitral Stenosis was the leading cause found in 50% of patients. 
 
TABLE 6 
SEVERITY OF MITRAL STENOSIS 
Valve Area No. of Cases Percentage 
> 1cm2 6 20% 
< 1cm2 24 80% 
 
Most of the cases were severe mitral stenosis with valve area <1cm2. 
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TABLE 7 
COMPLICATION 
Complications No. of Patients 
CCF 30 (60%) 
Thromboembolism 7 (14%) 
I.E 5 (10%) 
Congestive cardiac failure was the leading complication found in 60% of 
the patients. Whereas thromboembolism was found in only 14%. 
 
TABLE 8 
THROMBOEMBOLISM 
Thromboembolism 
 
Clot + 
No : (%) 
Clot – 
No : (%) 
Yes 5 (70) 2 (30) 
No 2(4) 41(96) 
Among the cases with thromboembolism almost 70% had left atrial clot 
with trans esophageal echo. 
Peripheral Embolism – 1 (15%) Central – 6 (85%) 
 
TABLE 9 
SEX RATIO  
Of the patients with embolism 70% were males. 
 
 
Male Female 
5 (70%) 2 (30%) 
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TABLE 10 
LEFT ATRIAL SIZE  
LA Size Total No. > 4 cm < 4cm 
Permanent /Persistent 
AF 46 40 6 
Paroxysmal  
AF 4 0 4 
 
Left atrial size more than 4cms was found in almost 87% of patients. 
 
 45
DISCUSSION 
An attempt has been made to study fifty cases of Atrial Fibrillation. 
• Mohan Nair et al1 concluded that atrial fibrillation is the most commonly 
sustained arrhythmia, being present in 0.4% of the overall population. This 
incidence is higher in countries with a high prevalence of rheumatic heart 
disease (RHD).  
• Jeff S. Healey et al14 Currently >2.2 million people in the United States 
have atrial fibrillation, and the annual incidence is approximately 19.2 per 
1,000 person-years  
 
 46
AGE DISTRIBUTION 
 
 In our study the age incidence is 21 -80 years with mean age of 43 years. 
46% of study population were between 21-40yrs.  46% between the age 
group of 41-60 yrs & 8% in the age group of 61-80yrs. 
 
 The mean age of the study population is 43 years in our study. Benjamin .O 
et al4 and Abdou Elhandy et al20 reported mean age as 58 & 67 in their 
respective studies. Maru8 reported 136 Ethiopian cardiac outpatients with 
AF in whom the mean age was 41 years. Crijns et al35 evaluated 127 
patients, the average age of their patients was 60 years all of the above 
mentioned studies correlates with our study. AFFIRM3 study reports mean 
age as 70 years, mean age in James et al study was 71 years. In the last two 
studies mentioned above age incidence is higher as most of their study 
population included were  above 50 years as the cause of atrial fibrillation 
differed from our study. 
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MALE INCIDENCE 
 
 56% of our study population were male which correlates with AFFIRM3 
study were the incidence in males were 61%.Abdou Elhendy20 reported 
male incidence as 66%, 52.63% male incidence was reported by Howard .S 
et al5. Framingham4 heart study showed greater incidence of atrial 
fibrillation in males. Feinberg31 also reported increased incidence in males. 
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ETIOLOGICAL ANALYSIS- RHD 
• In our study out of 50 case 70% (35 cases) had rheumatic heart disease as 
the cause for developing Atrial Fibrillation.Bernand L.J et al19 in their study 
concluded 70% of their study population had RHD as etiology. Maru8 
reported 136 Ethiopian cardiac outpatients with Atrial Fibrillation, in whom 
the mean age was 41 years, and the commonest cause was rheumatic heart 
disease (66%) ,Samuel levy et al6 found RHD to cause Atrial Fibrillation in 
33% of his study population.A.G Shaper15 reported that higher incidence of 
RHD is common in tropical countries.  
• Crijns et al35 evaluated the characteristics of 127 patients of atrial 
fibrillation. Valvular heart disease was the cause in  24% of his study 
population. 
• AFFIRM3 study reports very low incidence of rheumatic heart disease in 
their study, similarly Abdou et al20 reported low incidence. In western 
studies the most common cause of atrial fibrillation is hypertension as 
incidence of rheumatic fever is very low. 
• Studies done in tropical countries show rheumatic heart disease as the 
major cause of atrial fibrillation which co-insides with our study result.  
Western studies report hypertension and coronary artery disease as the main 
cause, as the prevalence of rheumatic fever leading to rheumatic heart 
disease is not so common in developed countries.         
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ETIOLOGICAL ANALYSIS – Coronary Artery Disease 
CAD is 2nd most common cause of atrial fibrillation with an incidence of 
12% in our study.  Samuel Levy et al6 reported 16.6% of their study population 
had CAD as a cause for atrial fibrillation.  In AFFIRM3 study CAD was presented 
38% of cases.  Howard S. Friedman5 reported 14% of cases.  Abdou Elhendy et 
al20 reported 34% of cases.  According to Gregory lip et al9 myocardial infarction 
complicates atrial fibrillation in 10-15% of cases.  According to Aberg H12 in his 
analysis of 463 patients with atrial fibrillation, coronary artery disease was the 
underlying cause in 23% of patients.  The above mentioned studies correlate with 
our study regarding coronary artery disease as risk factor, though in some studies 
the major causative factor was hypertension. 
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HYPERTENSION  
In our study the incidence of systemic hypertension was 8%. 
Crijns et al35 evaluated the characteristics of 127 patients with atrial fibrillation 
were he found . hypertension was the etiological factor in 16% of cases.  
Abergh12 in his analysis of 463 cases of atrial fibrillation noticed 34% of cases 
had systemic hypertension. 
According to Framingham4 study, hypertension accounted for about half of 
the cases. 
Hypertension was present in 71% of cases in AFFIRM3 study.  Abdou 
Elhendy et al20 reported incidence of systemic hypertension as 51% in their study. 
The incidence of Hypertension  in our study is much lesser than other trials. 
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SYMPTOM ANALYSIS 
• Most of the patients in our study population presented to emergency 
department with shortness of breath as their main complaint 70% (35 
patients) with overlapping of other symptoms. Palpitation was present in 30 
patients (60%) .Other complaints in decreasing order were chest pain 6% (3 
cases),weakness of limbs in 7 cases (14%) ,syncope in 1 case (2%), 
asymptomatic 5cases (10%). 
• . In the Canadian Registry of Atrial Fibrillation (CARAF)7, only 21% of 
patients were asymptomatic on presentation. Among the 79% of patients 
with symptoms, palpitations occurred in 50%, chest pain and fatigue in 
more than 25% and dizziness, presyncope or syncope in about 25%.As in 
our study palpitation was present in 60% of study population , chest pain 
present in 6%of cases. 
• Benjamin O. Koenig et al4 reported the following data in his study 
Presenting symptoms (%)  
Palpitations 57 (85) 
Chest pain 15 (22) 
Dizziness 12 (18) 
Shortness of breath 12 (18) 
Weakness 5 (7) 
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• The percentage of patients with shortness of breath varies from our study 
,other symptoms correlates. The number of patients included in their study 
was very high. 
Cardioversion 
15% of our study population were haemodynamically unstable and 
underwent emergency cardioversion.   
Benjamin et al4 in is study disclosed that emergency cardioversion was 
needed in 17% of his study population. 10% of cases who were haemodynamically 
unstable in the study done by Paul et al38 were cardioverted. 
Farhat Khairallah et al23 did Electrical cardioversion in 10% of  their study 
population. 
The above mentioned studies showed more or less similar percentage of 
patients who needed emergency cardioversion. 
Common Valvular Lesion in patients with RHD 
In our study MS+MR was present in 10 cases 28%, MS in 18cases, 50%, 
MR in 5 cases 16%,MR+AS+AR in 2 cases, 15%. 
The AFFIRM3 Investigators found that mitral regurgitation was present in 
15% of their cases 
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According to R Arora et al16 in their study of 2500 cases MS+MR was 
presented in 30%, MS was present in 38% of cases.  Cihangir Kazmay et al21 
reported MS in 70% of cases and MR in 30% 
Complications: 
In our study the most common complication is congestive cardiac failure 
60% (30 cases).  AFFIRM3 suggests that 32% of their patients had decreased left 
ventricular function.  According to O.T Samani26 congestive cardiac failure was 
presented in 64.9% of cases with atrial fibrillation. 
The common thought of increased incidence of thromboemobolic episode 
in atrial fibrillation is proven wrong, as per our study left ventricular dysfunction 
leading to heart failure is the most common complication. 
In our study 7 patients (14%) had thromboembolic episode, 6 of them being 
cerebral embolism which corresponds with cabin HS , et al13 who reported 
cerebral embolism in 85% of cases and peripheral embolism in 15% of cases. In 
our study  70% of patients with clinical features of embolism had left atrial clot 
and only 4% without embolism had it.Goswamy KC et al41 reported 26% 
incidence of LA clot in their study on 200cases of AF. They concluded that large 
left atrium & spontaneous echo contrast were associated with higher risk for clot 
formation. Rao42 AS et al in their study on 120 patients with mitral stenosis and 
AF by TEE observed LA thrombus in 34 patients (25%) compared with 21(16%) 
by TTE. In the study most left atrial appendage clots were missed by TTE . In our 
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study the incidence of LA clots by TEE was 7(14%) out of the fifty patients with 
AF. Among the patients 6 had rheumatic MS and total number cases of AF with 
MS was 30. The incidence being 20% which correlated with the above mentioned 
study. By TTE only 5 cases were detected to have clot. Yadav R et al43 in their 
study on 200 patients with MS reported 25% incidence for LA appendage clot and 
risk being higher in patients with older age, larger left atrium and atrial fibrillation.  
Left Atrial Dilatation 
87% (40 patients) of our study population had left atrial dilatation which 
correlates with AFFIRM3 study where left atrial dilatation was present in 67% of 
their study population. 
Study done by Zabalgoitia et al on 786 patients found out left atrial 
dilatation was present in 67% of cases, Adbou Elhendy et al20 in their study 
reported  81% of cases to have left atrial dilatation were mild enlargement 
observed in (41%) and marked enlargement seen in  (40%) of his study 
population.All the studies show high incidence of LA dilatation as per our study. 
LA size more than 4cm was found to be associated with permanent atrial 
fibrillation. 
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CONCLUSIONS 
1. AF is seen more commonly in men. 
2. Mean age of the study population was 43 years. 
3. Most common cause was RHD with mitral valve involvement. 
4. Common presenting symptom was dyspnoea. 
5. 15% of the patients with AF had significant haemodynamic instability 
requiring cardioversion. 
6. CCF was the most common complication in 60% of patients and CVA in 
14% of patients. 
7. Echo revealed LA dilatation in 80% of cases. 
8. LA clots were present in 14% of  all cases and in 70% of pts with  
embolism. 
9. Left atrial size more than 4cms was found to be related to permanent or 
persistent atrial fibrillation. 
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PROFORMA 
CLINICAL PROFILE OF ATRIAL FIBRILLATION 
 
NAME : 
AGE / SEX : 
I.P. No : 
Complaints on Admission : Duration: 
Shortness of Breath : 
 Palpitation : 
Chest Pain : 
Syncope : 
Weakness of limbs : 
Others : ( specified) 
 
Past History : Duration : 
DM : 
HTN : 
CAD : 
Hyper lipedemia : 
COPD/BA : 
RHD : 
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General Examination : 
 
Consciousness : 
Pallor, Ictirus, Clubing, Cyanosis, Lymphadenopathy,  
Pedal Edema 
JVP : 
 
Vitals  
Pulse rate : 
Pulse deficit : 
BP : 
Temperature : 
Respiratory Rate : 
SpO2 : 
 
Examination of systems: 
 
CVS : 
RS : 
CNS : 
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Abdomen : 
 
Haemodynamically Unstable Yes / No 
Labs : 
CBC : 
RFT : 
LFT : 
Sr. Electrolytes : 
Free T4 and TSH : 
ECG : 
ECHO : 
Valvular abnormality 
LA dilatation 
LA clot / Vegetation 
 
X-Ray Chest : 
Cardiomegaly  Yes / No 
Treatment : 
 
Outcome :      
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MASTER CHART 
 
TEE SL. 
No. Name Age Sex Etiology 
Type of 
Valve 
Disease 
Valve 
Area 
(Cm2) 
Cardio-
version CCF 
Thrombo-
embolism LA 
size 
LA 
clot 
H/o 
RF 
I.E
. 
CXR 
(Cardio-
megaly) 
1. Munian 40 M RHD MS <1 - + + 5 + + - - 
2. Kamatchi 30 F RHD MS <1 - + - 4.8 - + - - 
3. Raja 28 M RHD MS <1 - + - 4.3 - + - - 
4. Ramasamy 43 M RHD MS >1 + + - 4 + - - - 
5. Arumugam 48 M RHD MS+ MR >1 - - - 4 - - - + 
6. Meena 20 F CHD - - - + - 4.7 - - - - 
7. Veerasamy 60 M IHD - - - + - 4 - - - + 
8. Muniamma 51 F HTN - - - - - 3.8 - - - + 
9. Ramasamy 48 M RHD MS+AS+AR <1 + + + 5 + + - + 
10. Kanniammal 36 F Thy - - - - - 3.5 - - - - 
11. Kathiravan 47 M RHD MS+AS+AR <1 + + + 5 + + - + 
12. Karuppan 48 M RHD MS+AS+AR <1 + + + 5 + + - + 
13. Usha 36 F Thy - - - - - 3.5 - - - - 
14. Ethiraj 43 M RHD MS <1 - + + 5 + + - - 
15. Dhanalakshmi 18 F RHD MS <1 - + - 4.2 - + - - 
16. Samy 28 M RHD MS <1 - + - 4.3 - + - - 
17. Kandan 40 M RHD MS >1 + + - 4 + - - - 
18. Arul 48 M RHD MS+ MR >1 - - - 4 - - - + 
19. Roja 30 F RHD MS <1 - + - 4.1 - - - - 
20. Basha 61 M DCM - - - + - 4 - - - + 
21. Subbulakshmi 30 F RHD MS <1 - + - 4.5 - + - - 
22. Manickam 29 M RHD MS <1 - + - 4.3 - + - - 
23. Nandagopal 43 M RHD MS >1 + + - 4 + - - - 
24. Joseph 48 M RHD MS+ MR >1 - - - 4 - - - + 
25. Jothi 20 F RHD MS <1 - + - 4.9 - - - - 
26. Maahesh 47 M RHD MS <1 - + + 5 + + - - 
27. Vanitha 32 F RHD MS <1 - + - 4.1 - + - - 
28. Suresh 28 M RHD MS <1 - + - 4.3 - + - - 
29. Prakash 43 M RHD MS >1 + + - 4 + - - - 
30. Saravanan 52 M RHD MS+ MR >1 - - - 4 - - - + 
31. Sri Devi 20 F RHD MS <1 - + - 4.8 - - - - 
32. Aruchamy 62 M IHD - - - + - 4 - - - + 
33. Kandhimathi 55 F HTN - - - - - 3.8 - - - + 
34. Kulandaisamy 45 M RHD MS >1 + + - 4 + - - - 
35. Jayapal 49 M RHD MS+ MR >1 - - - 4 - - - + 
36. Ezhilarasi 20 F RHD MS <1 - + - 4.6 - - - - 
37. Kumanaraja 65 M IHD - - - + - 4 - - - + 
38. Delli 51 M RHD MS+AS+MR <1 + + + 5 + + - + 
39. Raji 30 F Thy - - - - - 3.5 - - - - 
40. Rajaram 40 M RHD MS <1 - + + 5 + + - - 
41. Jothiga 31 F RHD MS <1 - + - 4.2 - + - - 
42. Dass 36 M RHD MS <1 - + - 4.3 - + - - 
43. Thotti Jaya 43 M RHD MS >1 + + - 4 + - - - 
44. Pazhanivel 48 M RHD MS+ MR >1 - - - 4 - - - + 
45. Vijaya 20 F RHD MS <1 - + - 4.5 - - - - 
46. Kondaiah 63 M IHD - - - + - 4 - - - + 
47. Kanimozhi 30 F RHD MS <1 - + - 4.4 - + - - 
48. Praveen 34 M RHD MS <1 - + - 4.3 - + - - 
49. Mustafa 43 M RHD MS >1 + + - 4 + - - - 
50. Raghavan 53 M RHD MS+ MR >1 - - - 4 - - - + 
 
 
KEY TO MASTER CHART 
 
TEE   :  Transesophageal Echo 
RHD  :  Rheumatic Heart Disease 
DCM  : Dilated Cardiomyopathy 
LA  : Left Atrial 
RF  : Rheumatic Fever 
IHD  : Ischemic Heat Disease 
Thy  : Thyrotoxicosis 
HTN  : Hypertension 
CHD  : Congenital Heart Disease 
MS + MR : Mitral Stenosis + Mitral Regurgitation 
 
AR  : Aortic Regurgitation 
  
  
 
 
 
AETIOLOGICAL ANALYSIS - HYPERTENSION
0
10
20
30
40
50
60
70
80
Our study Abergh Ethopian epidiomology Abdou AFFIRM
  
 
 
 
AETIOLOGICAL ANALYSIS – CORONARY ARTERY DISEASE
0
5
10
15
20
25
30
35
40
Our study Howard Gregory lip Aberg.H AFFIRM study
  
 
 
 
SEX : MALE INCIDENCE
0
10
20
30
40
50
60
70
Our study Abdou AFFIRM Howard
  
 
 
MEAN AGE  
0
10
20
30
40
50
60
70
Our study Benjamin et al  AG Shaper et al Abdou et al AFFIRM
11-20 21-30 31-40 41-50 51-60 61-70
8 7 8 15 8 4
Male Female
54% 46%
BreathlessnessPalpitaion Weakness of limbsChest Pain Syncope
70% 60% 14% 6% 2%
RHD CHD ThyrotoxicosisIHD HTN Cardiomyopathy
70% 4% 4% 12% 8% 2%
MS MR MS+MR MS+AR+AS
50% 16% 28% 6%
CCF ThromboembolismI.E.
60% 14% 10%
Clot +ve Clot -ve
Yes 70% 30%
No 4% 96%
Valve Area <1cmValve Area > 1cm2 
80% 20%
> 4CM < 4CM
Permanent / Persistent AF40 6
Paroxysmal AF 0 4
8 7 8
15
8
4
0
2
4
6
8
10
12
14
16
11-20 21-30 31-40 41-50 51-60 61-70
AGE DISTRIBUTION
SEX DISTRIBUTION
54%
46%
Male Female
TYPE OF VALVULAR LESION
50%
16%
28%
6%
MS MR MS+MR MS+AR+AS
80%
20%
0%
10%
20%
30%
40%
50%
60%
70%
80%
Valve Area <1cm2 Valve Area > 1cm2 
SEVERITY OF MITRAL STENOSIS
40
0
6 4
0
10
20
30
40
> 4CM < 4CM
LEFT ATRIAL SIZE 
Permanent / Persistent AF Paroxysmal AF
SYMPTOM ANALYSIS
70%
60%
14% 6% 2%
Breathlessness Palpitaion Weakness of limbs
Chest Pain Syncope
70%
4% 4%
12%
8%
2%
0%
10%
20%
30%
40%
50%
60%
70%
RH
D CHD
Thy
roto
xico
sis IHD HTN
Car
diom
yop
athy
AETIOLOGICAL ANALYSIS
COMPLICATION
60%
14%
10%
CCF Thromboembolism I.E.
70%
4%
30%
96%
0%
20%
40%
60%
80%
100%
Clot +ve Clot -ve
THROMBOEMBOLISM 
Yes No

